Medical student education in transfusion medicine, part II: Moving forward to building up a "Know How" education program in transfusion medicine for under-graduate medical students.


Journal

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis
ISSN: 1473-0502
Titre abrégé: Transfus Apher Sci
Pays: England
ID NLM: 101095653

Informations de publication

Date de publication:
Dec 2020
Historique:
received: 12 06 2020
revised: 09 07 2020
accepted: 13 07 2020
pubmed: 29 7 2020
medline: 6 8 2021
entrez: 29 7 2020
Statut: ppublish

Résumé

There is a general trend in changing paradigm in teaching medicine; the emerging concept relies on a competence-based approach. Transfusion is either a discipline or a subsidiary of others depending on the countries and systems; this variability can be explained because transfusion is a medical care that is transdisciplinary. As a collective of professionals in both transfusion medicine practice and education, authors aim to propose a revision of the way education in transfusion medicine is delivered in this era of the 'global competency approach'. They advocate in favor of a Know How on 5 key issues: Diagnosing the patient condition in line with the Patient Blood Management principles; Facing acute blood loss; Addressing compatibility and avoiding immunization; Seeking for maximized benefits and dampening complications; and Inlaying competence within global health care issues, also comprising od economy. The methods used would be those developed for medical education at large, such as assessment tools. The global objective is to deliver the necessary competence to manage patients by an intern/resident. At the end of the curriculum, students should be able to self-evaluate the following items: 1) Do I know why my patient is anemic, thrombocytopenic, bleeding….? 2) Do I know the best approach to treat anemia, thrombocytopenia, bleeding (including the "no treatment" option)? 3) Do I know whether a transfusion approach is appropriate for my patients? 4) Do I know how to evaluate and anticipate benefits from blood transfusion and to avoid side-effects in the patient? 5) Do I know how to avoid unnecessary use of the products?

Identifiants

pubmed: 32718832
pii: S1473-0502(20)30184-1
doi: 10.1016/j.transci.2020.102879
pii:
doi:

Types de publication

Journal Article

Langues

eng

Pagination

102879

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Olivier Garraud (O)

Faculty of Medicine of Saint-Etienne, University of Lyon, Saint-Etienne, France; Institut National De La Transfusion Sanguine, Paris, France; Palliative Care Unit, Ruffec Hospital, Ruffec, France. Electronic address: ogarraud@ints.fr.

Tomislav Vuk (T)

Croatian Institute of Transfusion Medicine, Zagreb, Croatia; Josip Juraj Strossmayer University of Osijek - Faculty of Medicine, Osijek, Croatia.

Anneke Brand (A)

Transfusion Medicine, Leiden University Medical Center, Leiden University, the Netherlands.

Vincenzo de Angelis (V)

Department of Transfusion Medicine, Udine University Hospital, Italy.

Constantina Politis (C)

Coordinating Haemovigilance Centre (SKAE), Hellenic Centre for Disease Control and Prevention, Athens, Greece.

Antoine Haddad (A)

Faculty of Medicine of Saint-Etienne, University of Lyon, Saint-Etienne, France; Department of Clinical Pathology and Blood Bank, Sacre-Coeur Hospital, Lebanese University, Beirut, Lebanon.

Alexander P J Vlaar (APJ)

Department of Intensive Care Medicine, Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, Location AMC, Amsterdam, the Netherlands.

Miquel Lozano (M)

Clinic University Hospital Barcelona, University of Barcelona, Spain.

Nigar Ertuğrul Örüç (N)

Health Sciences University Diskapi Yildirim Beyazit Training and Research Hospital, Ankara, Turkey.

Stefan Laspina (S)

Department of Pathology, Mater Dei Hospital, Malta.

Jean-Daniel Tissot (JD)

Faculte De Biologie Et De Medecine, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH